WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...

On 17 December 2025, the World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests ...

Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, summarizes the practical parts of the 2023 ACVIM consensus update on leptospirosis and explains what it means for general practice. She covers the biggest shift ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

TrinScreen HIV order signals renewed strength in global HIV testing market- Company also reports a key milestone of Adjusted EBITDA1positive ...

The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new ...

COVID-19 infections are rising again across the U.S. Here's which symptoms to look for and how to protect yourself over the ...

Gorakhpur: Conventional smear microscopy, though widely used in India, misses detection of many tuberculosis (TB) cases, ...

IntroductionThe global critical care diagnostics market is poised for steady expansion, projected to grow at a CAGR of around 6% over the next five years. This growth trajectory is supported by ...

Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.

OverviewThe global infectious disease diagnostics market is poised for steady expansion, with forecasts indicating a CAGR of approximately 7% over the next five years. This growth trajectory is ...